Jordan Julie bought NGNE
February 20, 2026 · Form 4 insider transaction
Jordan Julie bought 29,600 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,600
Price
$0.00
Total value
N/A
InsiderJordan Julie
RoleOfficer
CompanyNeurogene Inc. (NGNE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 24, 2026
Shares owned after29,600
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents the right to purchase 29,600 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.